Australia Imposes New Restrictions on Prescribing Ivermectin for COVID-19

The logo of the Therapeutic Goods Administration is seen at a COVID-19 vaccines press conference in Canberra, Australia, on May 6, 2021. AAP Image/Lukas Coch

Australia’s medicine and therapeutics regulator, the Therapeutic Goods Administration (TGA), has introduced new restrictions on the prescribing of ivermectin for COVID-19 and other off-label use.

The TGA, an agency under Australia’s Department of Health, announced that the changes were introduced “because of concerns with the prescribing of oral ivermectin for the claimed prevention or treatment of COVID-19.”